# CVM GFI #229 Evaluating the Effectiveness of New Animal Drugs for the Reduction of Pathogenic Shiga Toxin-Producing E coli in Cattle - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-229-evaluating-the-effectiveness-of-new-animal-drugs-for-the-reduction-of-pathogenic-shiga-toxin-producing-e-coli-in-cattle/cafa51a7-9df8-4840-9877-123cd25c033d

> FDA guidance document: CVM GFI #229 Evaluating the Effectiveness of New Animal Drugs for the Reduction of Pathogenic Shiga Toxin-Producing E coli in Cattle. Issue date: October 19, 2015. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #229 Evaluating the Effectiveness of New Animal Drugs for the Reduction of Pathogenic Shiga Toxin-Producing E coli in Cattle
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2015-10-19
- Comment Close Date: 2015-04-27
- Last Changed: 2019-04-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2015-D-0235">FDA-2015-D-0235</a>

## Related Documents

- [CVM GFI #231 Distributor Labeling for New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-231-distributor-labeling-for-new-animal-drugs/f3f085c4-37b6-4386-8e93-136bc258ba82)
- [CVM GFI #218 Cell-Based Products for Animal Use](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-218-cell-based-products-for-animal-use/75ff952d-26bc-416e-befa-98465a1b4db9)
- [CVM GFI #211 Residual Solvents in Animal Drug Products Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-211-residual-solvents-in-animal-drug-products-questions-and-answers/9781e148-95e8-460b-a7c3-cbef9ad9cd69)